TD Asset Management’s Legend Biotech LEGN Stock Holding History
Bought
Maintained
Sold
Other funds holding LEGN
HA
SCM
DM
B
TD Asset Management's LEGN Position: Q3 2025 in Review
TD Asset Management sold out of Legend Biotech (LEGN) in Q3 2025, closing a stake of 103,392 shares — an estimated $3.67M sold.
TD Asset Management first reported a position in LEGN in Q2 2020 and held it in 16 quarters. The position peaked at $18.2M in Q3 2023. 200 funds tracked by Wall St. Rank hold LEGN as of Q3 2025.
- TD Asset Management reported no remaining Legend Biotech position as of Q3 2025 after selling out during the quarter.
- TD Asset Management sold 103,392 Legend Biotech shares in Q3 2025, an estimated $3.67M.
- TD Asset Management first reported a position in Legend Biotech in Q2 2020 and held it in 16 quarters.
- TD Asset Management's Legend Biotech position peaked at $18.2M in Q3 2023.
- 200 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2025.
Based on TD Asset Management's 13F filing for Q3 2025, filed 10 Nov 2025.